Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2010
10/06/2010CN101850079A Chinese medicament for treating asthma
10/06/2010CN101850073A Chinese medicinal composition for treating chronic pharyngitis
10/06/2010CN101850067A Chinese medicinal composition for treating chronic pharyngitis
10/06/2010CN101850053A Pharmaceutical composition containing Japanese stephania root
10/06/2010CN101850051A Fritillaria lung-moistening capsule
10/06/2010CN101850043A Application of crex rigescens in preparation of medicament for resisting respiratory syncytial virus
10/06/2010CN101850032A Anti-tumor traditional Chinese medicine composition and preparation method and application thereof
10/06/2010CN101850017A Chinese medicament for treating asthma
10/06/2010CN101850014A Chinese medicament for treating asthma
10/06/2010CN101850013A Chinese medicinal nose drops for treating colds and quality control method and application of preparation thereof
10/06/2010CN101850008A Bacillus Ling oral liquid and preparation method thereof
10/06/2010CN101850007A Improvement on hydrolysis process for insoluble animal ingredient in Qingkailing
10/06/2010CN101849992A Medicament for treating inferior turbinate hypertrophy and method for preparing same
10/06/2010CN101849991A Magnolia biondii pamp volatile oil nanoliposome freeze-dried powder, temperature-sensitive magnolia biondii pamp nanogel and preparation method thereof
10/06/2010CN101849987A Preparation of Chinese angelica and astragalus root mixture ethanol extract and aqueous extract and application in intervening in pulmonary fibrosis
10/06/2010CN101849972A Banding detection method of Cordyceps sinensis DNA fingerprint high resolution ratio
10/06/2010CN101849948A Cefuroxime axetil composite medicine
10/06/2010CN101849939A Medicinal composition taking ipratropium bromide and salbutamol as main active ingredients
10/06/2010CN101849928A Inhalation preparation for treating asthma, preparation method and application thereof
10/06/2010CN101849927A Hot-melt pressure-sensitive adhesive transdermal patch containing alpha-asarone and preparation method thereof
10/06/2010CN101849917A Orodispersible tablets containing fexofenadine
10/06/2010CN101849913A Method for preparing veterinary florfenicol lung targeting gelatin microsphere
10/06/2010CN101849902A Preparation method of solid pharmaceutical composition containing desloratadine
10/06/2010CN101317974B Traditional Chinese medicine for treating wind-cold
10/06/2010CN101297862B Capsule for treating rhinitis
10/06/2010CN101279048B Chinese medicine for curing cold mainly and preparation thereof
10/06/2010CN101234165B Pharmaceutical combination for treating asthma or rhinitis and preparation thereof
10/06/2010CN101181408B Chinese medicine composition for the oral medication of chronic sinusitis
10/06/2010CN101112509B Oral administration Chinese traditional medicine composition for treating chronic sinusitis
10/06/2010CN101108206B Method of preparing cortex mori radicis extractive with glycosidase restraint function
10/06/2010CN101095670B Luteolin phospholipid complexes and method for preparing the same and application thereof
10/06/2010CN101073563B Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
10/06/2010CN101066343B Externally applied Chinese medicine for treating tonisillitis and lymphnoditis and its preparation process
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807658 Administering an optionally substituted 3-aminopropylphosphinic acid (3-amino-2-fluoropropyl)phosphinic acid, 3-amino-2-oxopropyl)phosphinic acid); irritable bowel syndrome
10/05/2010US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors
10/05/2010CA2455167C New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
09/2010
09/30/2010WO2010111527A1 Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
09/30/2010WO2010111503A2 RNA INTERFERENCE MEDIATED INHIBITION OF THE HIGH AFFINITY IGE RECEPTOR ALPHA CHAIN (FCεRLα) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
09/30/2010WO2010111471A2 RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/30/2010WO2010111468A2 RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
09/30/2010WO2010111464A1 RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/30/2010WO2010110760A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
09/30/2010WO2010110748A1 Use of andrographolide compounds for treating inflammation and airway disorders
09/30/2010WO2010110747A1 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid
09/30/2010WO2010108856A1 Leukotriene b4 inhibitors
09/30/2010WO2010075090A3 Scopine modulators of muscarinic acetylcholine receptor
09/30/2010US20100249200 Novel Compounds 569
09/30/2010US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249162 Process for the introduction of hydroxyethoxy side chain in bosentan
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010US20100249137 Novel sEH Inhibitors and Their Use
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249095 Substituted Spiro-amide Compounds
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249087 Compounds as cannabinoid receptor ligands
09/30/2010US20100249086 Compounds As Cannabinoid Receptor Ligands
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249084 Substituted pyrimidines as adenosine receptor antagonists
09/30/2010US20100249079 Analogues of cilostazol
09/30/2010US20100249057 Trehalose compound and pharmaceutical comprising the compound
09/30/2010US20100249034 Gfralpha3 and its uses
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249019 Use of a peptide as a therapeutic agent
09/30/2010US20100249017 Use of cnp-22, alone or in combination with physalemin, as a therapeutic agent
09/30/2010US20100247682 Use of nitrite salts for the treatment of cardiovascular conditions
09/30/2010US20100247658 Organic compounds
09/30/2010US20100247585 Stabilized pharmaceutical product
09/30/2010US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof
09/30/2010US20100247538 IL-18 and Protein Kinase R Inhibition for the Treatment of COPD
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247524 Methods for treating Chronic Obstructive Pulmonary Disease
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247461 Anti-inflammatory complexes
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010CA2747327A1 Leukotriene b4 inhibitors
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2231676A1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo[a,d]-cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
09/29/2010EP2231669A1 Phosphodiesterase inhibitors
09/29/2010EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231630A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl]cyclobut anecarboxamide
09/29/2010EP2231280A2 Organic compounds
09/29/2010EP1940409B1 Novel pharmaceutical combinations for the treatment of respiratory disorders
09/29/2010EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 878